Author:
Schrier Vergano Samantha A.
Publisher
Springer Nature Switzerland
Reference55 articles.
1. Adams, A. D., Fiesco-Roa, M., Wong, L., Jenkins, G. P., Malinowski, J., Demarest, O. M., et al. (2023). Phenylalanine hydroxylase deficiency treatment and management: A systematic evidence review of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine, 25(9). https://doi.org/10.1016/j.gim.2022.12.005
2. Ah Mew, N., Simpson, K. L., Gropman, A. L., Lanpher, B. C., Chapman, K. A., & Summar, M. L. (1993). Urea cycle disorders overview. In GeneReviews® [Internet]. University of Washington, Seattle.
3. Amaral, A. U., & Wajner, M. (2022, July 1). Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain α-keto acids. Neurochemistry International. Elsevier Ltd. https://doi.org/10.1016/j.neuint.2022.105360
4. Blackburn, P. R., Gass, J. M., Pinto e Vairo, F., Farnham, K. M., Atwal, H. K., Macklin, S., et al. (2017, September 6). Maple syrup urine disease: Mechanisms and management. Application of Clinical Genetics. Dove Medical Press Ltd. https://doi.org/10.2147/TACG.S125962
5. Clarke, L. A. (1993). Mucopolysaccharidosis type I. In GeneReviews® [Internet]. University of Washington, Seattle.